JASUB Property Holdings LLP has filed a mandatory disclosure regarding a substantial change in its shareholding, along with its Persons Acting in Concert (PACs), in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals). The acquisition, which took place on February 18, 2026, involved an inter-se transfer through Block Deals, resulting in the group’s total voting capital increasing to 6.36% of the Target Company.
Mandatory Disclosure of Shareholding Change
JASUB Property Holdings LLP submitted a disclosure to the Stock Exchanges concerning a substantial acquisition/disposal of shares in COHANCE LIFESCIENCES LIMITED (formerly Suven Pharmaceuticals Limited). This filing is made pursuant to the SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011, detailing changes in the holding of the acquirer and its Persons Acting in Concert (PACs).
Acquisition Details
The transaction date for the acquisition was February 18, 2026. The mode of acquisition was an Inter-se transfer through Block Deals. The securities acquired were Equity shares carrying voting rights. The filing notes that a portion of the holding, specifically 8,76,948 shares (0.23%), was sold in the open market between September 2025 and January 2026 prior to the final calculation.
Holding Before Acquisition
Prior to this transaction, the total voting capital held by the Acquirer (JASUB Property Holdings LLP) and its PACs stood at 6.42%, representing 2,52,02,957 shares. The largest contributor to this pre-acquisition holding was Jasti Property and Equity Holdings Private Limited (as trustee of the Jasti Family Trust) with 6.59% (2,51,92,957 shares).
Holding After Acquisition
The acquisition involved the group acquiring 70,00,000 shares, equating to 1.83% of the total share capital. Following the transaction, the consolidated post-acquisition holding for the entire group stands at 6.36% of the total voting capital, which amounts to 2,43,26,009 shares.
- JASUB Property Holdings LLP (Acquirer): Holds 1.78% (70,00,000 shares).
- Jasti Property and Equity Holdings Private Limited (PAC): Holds 4.42% (1,73,16,009 shares).
Capital Structure Context
The total equity share capital/total voting capital of the Target Company (TC) remained constant both before and after the acquisition at 38,25,67,140 equity shares. However, the total diluted share/voting capital of the TC post-acquisition is stated as 39,22,07,995 shares.
Source: BSE
